PAX5 is a tumor suppressor in B-ALL, while the role of PAX5 fusion proteins in B-ALL development is largely unknown. Here, we studied the function of PAX5-ETV6 and PAX5-FOXP1 in mice expressing these proteins from the Pax5 locus. Both proteins arrested B-lymphopoiesis at the pro-B to pre-B-cell transition and, contrary to their proposed dominant-negative role, did not interfere with the expression of most regulated Pax5 target genes. Pax5-Etv6, but not Pax5-Foxp1, cooperated with loss of the Cdkna2a/b tumor suppressors in promoting B-ALL development. Regulated Pax5-Etv6 target genes identified in these B-ALLs encode proteins implicated in pre-B-cell receptor (BCR) signaling and migration/adhesion, which could contribute to the proliferation, survival, and tissue infiltration of leukemic B cells. Together with similar observations made in human PAX5-ETV6+ B-ALLs, these data identified PAX5-ETV6 as a potent oncoprotein that drives B-cell leukemia development.

, , , ,
doi.org/10.15252/embj.201695495, hdl.handle.net/1765/98150
EMBO Journal
Erasmus MC: University Medical Center Rotterdam

Smeenk, L. (Leonie), Fischer, M. (Maria), Jurado, S. (Sabine), Jaritz, M. (Markus), Azaryan, A. (Anna), Werner, B. (Barbara), Roth, M. (Mareike), Zuber, J., Stanulla, M., den Boer, M., Mullighan, C., Strehl, S.& Busslinger, M. (2017). Molecular role of the PAX5-ETV6 oncoprotein in promoting B-cell acute lymphoblastic leukemia. EMBO Journal.https://doi.org/10.15252/embj.201695495